MARKET

ADGM

ADGM

Adagio Medical
NASDAQ
1.180
+0.349
+41.95%
After Hours: 1.145 -0.035 -2.97% 16:19 12/16 EST
OPEN
0.9700
PREV CLOSE
0.8313
HIGH
1.250
LOW
0.9500
VOLUME
1.10M
TURNOVER
--
52 WEEK HIGH
2.870
52 WEEK LOW
0.6250
MARKET CAP
24.99M
P/E (TTM)
-0.2482
1D
5D
1M
3M
1Y
5Y
1D
Adagio Medical Holdings Inc. Held Annual Shareholder Meeting
Reuters · 38m ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 4h ago
Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Benzinga · 11h ago
Adagio Medical Holdings CEO Todd Usen Acquires Common Shares
Reuters · 19h ago
Weekly Report: what happened at ADGM last week (1208-1212)?
Weekly Report · 1d ago
Adagio Medical Holdings Inc. Files Initial Statement of Beneficial Ownership for Director Sean Salmon
Reuters · 4d ago
Adagio Medical Expands Board with New Appointment
TipRanks · 4d ago
Adagio Medical Holdings Appoints Sean Salmon to Board of Directors
Reuters · 5d ago
More
About ADGM
Adagio Medical Holdings, Inc. is a commercial stage medical device company. It is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. It is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.

Webull offers Adagio Medical Holdings Inc stock information, including NASDAQ: ADGM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADGM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADGM stock methods without spending real money on the virtual paper trading platform.